Purchase Order 75N94022P00579

Award Date 8/2/22
Potential Completion Date 8/1/23
Potential Value $387K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80309, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $152,122.00 firm-fixed-price purchase order to The Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division. The award is to perform the clinical work associated with studies of diabetic kidney disease in type 1 and type 2 diabetes. This award was not set aside...
This firm-fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to the University of Colorado (Boulder, CO) to perform biostatistical analyses of data generated in studies of diabetic kidney disease. The $51,200 contract has a completion date of July 31, 2023 and was awarded on August 1, 2022 without a set-aside designation. As a public research university, the University of Colorado has an extensive...
The Department of Health and Human Services' National Institutes of Health awarded a $146,720.00 Firm Fixed Price Purchase Order to The Regents of the University of Colorado, doing business as the University of Colorado Denver, to provide services for running iohexol and p-aminohippurate clearance studies, administering furosemide injections during kidney MRI scanning, and conducting hyperinsulinemic-euglycemic and hyperglycemic clamps in support of collaborative research studies on the...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $15,000.00 firm fixed-price purchase order to The Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division, for the "REPROGRAMMING OF COLLECTED PERIPHERAL BLOOD" project. The University of Colorado is a U.S. state government entity and accredited public research university that conducts fundamental research across science,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $16,100 firm fixed price purchase order to Mary Cecelia Kirker doing business as Mary C Kirker. The place of performance will be in Rockville, Maryland. The period of performance is from July 13, 2023 to July 12, 2024. As the National Institute of Diabetes and Digestive and Kidney Diseases conducts research related to diabetes, digestive...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $164,544.00 firm-fixed-price purchase order contract to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, for kidney processing services. The contract does not have a set-aside designation. The Regents of the University of Minnesota is a non-profit organization and 1862 land grant...
This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Children's Research Institute, a subsidiary of the Children's National Medical Center, for $23,332.97. The contract is for research recruitment and services related to the NIDDK Youth and Young Adult Diabetes Research Program. The work will be performed in Washington, D.C. and has a completion date of September 27, 2023. This contract award does...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $80,095.43 firm fixed price delivery order against the General Services Administration (GSA) Multiple Award Schedule to Shimadzu Scientific Instruments, Inc. for a preparatory high performance liquid chromatography (HPLC) system. Performance will take place in Columbia, Maryland from June 30, 2023...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded an $8,374.25 purchase order to Hielscher Usa, Inc. for laboratory equipment. The firm fixed price contract will provide the equipment to the agency's location in Bethesda, Maryland over a period of performance from August 9th to September 30th, 2016. No additional details were provided regarding the specific equipment or services requested under...

The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $387,422 firm fixed price purchase order to the Regents of the University of Colorado Office of Contracts and Grants Division, doing business as the University of Colorado in Boulder. The contract calls for the prime contractor to perform state-of-the-art measurements in studies of diabetic kidney disease in type 1 and type 2 diabetes. Specifically, the contractor will provide ultrasound guided kidney biopsies, kidney and brain MRIs, PET scans using C-11 acetate, clearance studies, endovascular biopsies, pulse wave analysis, and biomarker measurements from blood and urine samples. The period of performance is from August 2, 2022 through August 1, 2023. There is no designated set-aside. The solicitation sought these technical services to support research into diabetic kidney disease for 50 participants each for MRIs and clearance studies, 30 for PET scans, 20 for kidney biopsies, 50 for endovascular biopsies, and biomarker measurements and induced pluripotent stem cell reprogramming for 100 and 8 participants respectively.

Generated 12/29/23, 3:42 PM